Randomized Study to Evaluate the Use of High-Dose Therapy as Part of Primary Treatment for “Aggressive” LymphomaUlrich Kaiser, K. Havemann, Irmgard Uebelacker et al.|Journal of Clinical Oncology|2002Cited by 139
Multi-omic based molecular profiling of advanced cancer identifies treatable targets and improves survival in individual patientsAlexandra Samsen, Hartmut Juhl, Bernd Flath et al.|Oncotarget|2018Cited by 4